
American Headache Society 65th Annual Scientific Meeting (AHS 2023)
Austin, Texas 16 June 2023 - 18 June 2023
Fremanezumab eases migraine and depressive symptoms
13 Jul 2023
byElvira Manzano
Treatment with fremanezumab – an anticalcitonin gene-related peptide (CGRP) – reduces depressive symptoms in patients with migraine and comorbid major depressive disorder (MDD) in the UNITE trial.